Berkshire Hathaway (BRK.B) (BRK.A) announced it has completed the acquisition of OxyChem from Occidental (OXY) for $9.7B, subject to customary post-closing purchase price adjustments. OxyChem will continue to be managed by Wade Alleman, OxyChem president and CEO.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRK.A:
- Berkshire Hathaway’s Buffett believes company can last a century, CNBC says
- Berkshire Hathaway Announces Key Leadership Changes
- Midday Fly By: IBM to buy Confluent, Paramount goes hostile for Warner Bros.
- JPMorgan names Todd Combs as head of Strategic Investment Group
- Berkshire Hathaway announces CFO Marc Hamburg to retire on June 1, 2027